Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammadsaleh Jahangir"'
Autor:
Mohammadsaleh Jahangir, Omid Yazdani, Mohammad Saeed Kahrizi, Sara Soltanzadeh, Hamidreza Javididashtbayaz, Azam Mivefroshan, Saba Ilkhani, Romina Esbati
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade therapy has become a game-changing therapeutic approach revolutionizing the treatment setting of human malignancies, such as renal cell carcinoma (RCC). Despite the remarka
Externí odkaz:
https://doaj.org/article/542f94dda9774f63b2b3f940499849a7
Autor:
Mohaddeseh Rahbaran, Angelina Olegovna Zekiy, Mahta Bahramali, Mohammadsaleh Jahangir, Mahsa Mardasi, Delaram Sakhaei, Lakshmi Thangavelu, Navid Shomali, Majid Zamani, Ali Mohammadi, Negin Rahnama
Publikováno v:
Cellular & Molecular Biology Letters, Vol 27, Iss 1, Pp 1-36 (2022)
Abstract Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a myriad of studies in animal models and also some clinical trials have e
Externí odkaz:
https://doaj.org/article/2152fdca69a7428281bfed6aab9d0c75
Autor:
Mohammadsaleh Jahangir, Mohammad Saeed Kahrizi, Mohammad Natami, Raziyeh Moaref Pour, Shadi Ghoreishizadeh, Maryam Hemmatzadeh, Hamed Mohammadi, Navid Shomali, Siamak Sandoghchian Shotorbani
Publikováno v:
Molecular Biology Reports. 50:553-563
Ankylosing spondylitis (AS) is a progressive inflammatory disease. Our primary objective was to explore the role of miR-155 and its targeted factors in AS pathogenesis.PBMCs were isolated from 30 AS patients and 30 healthy individuals using the Ficol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c85372cf59334453d305cbc3a2b84e4
https://doi.org/10.1007/s11033-022-08033-5
https://doi.org/10.1007/s11033-022-08033-5
Autor:
Negin Rahnama, Mohammadsaleh Jahangir, Samira Alesaeid, Mohammad Saeed kahrizi, Ali Adili, Rebar N. Mohammed, Ramin Aslaminabad, Morteza Akbari, Ali Mert Özgönül
Publikováno v:
Pathology - Research and Practice. 236:153982
Pancreatic duct adenocarcinoma, commonly known as pancreatic cancer (PC), is a cancer-related cause of death due to delayed diagnosis, metastasis, and drug resistance. Patients with PC suffer from incorrect responses to chemotherapy due to inherent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f34227dc46b80229992c302d7d99ce4
https://doi.org/10.1016/j.prp.2022.153982
https://doi.org/10.1016/j.prp.2022.153982